In Vivo Knee Motion and ACL Biomechanics During Dynamic Activities
In Vivo Knee Motion and ACL Biomechanics During Dynamic Activities
批准号:
10225467
负责人:
Louis E. DeFrate
金额:
$63.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
未结题
起止时间:
2014-05-01 至 2025-07-31
关键词:
AffectAgeBiologicalBiological FactorsBiological MarkersBiomechanicsBody Weight decreasedBody mass indexCartilageCharacteristicsClinicalCluster AnalysisDataData SetDegenerative polyarthritisDevelopmentDiagnostic radiologic examinationEtiologyFutureHealthHomeostasisImageInflammation MediatorsInflammatoryInjuryInterventionJointsKneeLubricationMachine LearningMagnetic Resonance ImagingMeasurementMeasuresMechanicsMetabolicMetabolismMotionOperative Surgical ProceduresPainParticipantPathway interactionsPatient Outcomes AssessmentsPatientsPharmacologic SubstancePhenotypePhysical therapyPlayPreventionReconstructive Surgical ProceduresRelaxationRiskRoleSerumSiteSpeedStatistical ModelsSynovial FluidTechniquesThickTimeValidationWalkingWorkanterior cruciate ligament injuryanterior cruciate ligament reconstructionarticular cartilagecartilage degradationclinical phenotypedemographicsearly onsetexperiencehigh riskhigh risk populationimprovedin vivoinnovationjoint destructionjoint inflammationmeniscus injurynovelpredictive modelingpreventpsychosocialrandom forestreconstructionresponsesextargeted treatmentthree-dimensional modelingtreadmill
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract: Radiographic evidence of OA is present in more than 50% of patients 10 years after ACL
reconstruction. However, the etiology of early onset OA after ACL reconstruction is not well understood. While
previous work has demonstrated changes in joint motion following reconstruction, it is unclear how these altered
motions relate to changes in the local mechanical response of cartilage to in vivo loading. This information may
be critical to understanding the onset of OA, as the mechanical response of cartilage affects cartilage
homeostasis. In line with this mechanism, our pilot data indicates that regions of high cartilage strain measured
in patients with ACL injury and reconstruction are susceptible to decreased cartilage thickness, a characteristic
feature of OA. Importantly, these degenerative changes are observed as early as 18 months post-reconstruction.
Therefore, in this proposal our overall hypothesis is that site-specific changes in the mechanical response
of cartilage to loading following ACL injury and reconstruction are predictive of long-term cartilage
degeneration. Specifically, we hypothesize that in regions of cartilage experiencing elevated strain during
loading, early degeneration will be reflected by altered composition and decreased cartilage thickness. Thus, we
will measure localized cartilage strain, composition, and thickness at four time-points: after ACL injury but prior
to reconstruction, as well as at 3 months, 1 year, and 2 years after surgery. At each time point, a combination of
high-speed biplanar radiography and MR imaging will be used to measure local cartilage strains during in vivo
loading. To assess cartilage degeneration, we will use MRI to measure site-specific changes in composition
(using T1rho and T2 relaxation times) and cartilage thickness. Additionally, our analyses will account for relevant
biological variables such as age, sex, and BMI, and clinical factors such as graft placement characteristics and
meniscus injuries. In addition to mechanical factors, biological factors such as joint inflammation and lubrication
may also play a role in cartilage degeneration after ACL reconstruction. Therefore, synovial fluid and serum will
be collected to measure inflammatory mediators and metabolic biomarkers. Using this data, we will develop a
predictive model of cartilage degeneration after ACL reconstruction that utilizes both mechanical and biological
factors, as well as other demographic and clinical characteristics, to predict declines in cartilage health.
Furthermore, this comprehensive dataset will be used to develop clinical phenotypes to identify those at high
risk for cartilage degradation after ACL reconstruction. Importantly, the development of these phenotypes will
enable targeted treatment approaches focusing on surgical procedures, pharmaceutical targets, and non-
pharmacological interventions such as physical therapy or weight loss in preventing cartilage degeneration.
Therefore, our findings will both elucidate the role of alterations in the local mechanical response of cartilage on
degeneration after ACL reconstruction and improve the identification and treatment of patients at high risk for
cartilage degeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2022 Musculoskeletal Biology & Bioengineering Gordon Research Conference & Gordon Research Seminar
-
批准号:10378272
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2022
-
负责人:Louis E. DeFrate
-
依托单位:
Biomechanical and Biological Predictors of Cartilage Health Following Meniscus Injury
-
批准号:10383708
-
项目类别:
-
资助金额:$67.98万
-
财政年份:2021
-
负责人:Louis E. DeFrate
-
依托单位:
Biomechanical and Biological Predictors of Cartilage Health Following Meniscus Injury
-
批准号:10230722
-
项目类别:
-
资助金额:$69.65万
-
财政年份:2021
-
负责人:Louis E. DeFrate
-
依托单位:
Biomechanical and Biological Predictors of Cartilage Health Following Meniscus Injury
-
批准号:10588182
-
项目类别:
-
资助金额:$68.1万
-
财政年份:2021
-
负责人:Louis E. DeFrate
-
依托单位:
Biomechanical and Biological Predictors of Cartilage Health Following Meniscus Injury
-
批准号:10751974
-
项目类别:
-
资助金额:$6.72万
-
财政年份:2021
-
负责人:Louis E. DeFrate
-
依托单位:
Mechanical Biomarkers of Chronic Low Back Pain
-
批准号:10665590
-
项目类别:
-
资助金额:$62.73万
-
财政年份:2019
-
负责人:Louis E. DeFrate
-
依托单位:
Mechanical Biomarkers of Chronic Low Back Pain
-
批准号:10440260
-
项目类别:
-
资助金额:$61.68万
-
财政年份:2019
-
负责人:Louis E. DeFrate
-
依托单位:
Mechanical Biomarkers of Chronic Low Back Pain
-
批准号:10171398
-
项目类别:
-
资助金额:$60.43万
-
财政年份:2019
-
负责人:Louis E. DeFrate
-
依托单位:
Weight loss, in vivo cartilage mechanics, and joint health
-
批准号:10091305
-
项目类别:
-
资助金额:$34.36万
-
财政年份:2019
-
负责人:Louis E. DeFrate
-
依托单位:
Weight loss, in vivo cartilage mechanics, and joint health
-
批准号:10536658
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2019
-
负责人:Louis E. DeFrate
-
依托单位:
Mechanical Biomarkers of Chronic Low Back Pain
-
批准号:9981627
-
项目类别:
-
资助金额:$62.3万
-
财政年份:2019
-
负责人:Louis E. DeFrate
-
依托单位:
Weight loss, in vivo cartilage mechanics, and joint health
-
批准号:10319492
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2019
-
负责人:Louis E. DeFrate
-
依托单位:
In Vivo Knee Motion and ACL Biomechanics During Dynamic Activities
-
批准号:10450140
-
项目类别:
-
资助金额:$65.14万
-
财政年份:2014
-
负责人:Louis E. DeFrate
-
依托单位:
In Vivo Cartilage Mechanics and Degeneration After ACL Deficiency
-
批准号:8514773
-
项目类别:
-
资助金额:$7.83万
-
财政年份:2013
-
负责人:Louis E. DeFrate
-
依托单位:
In Vivo Cartilage Mechanics and Degeneration After ACL Deficiency
-
批准号:8641656
-
项目类别:
-
资助金额:$7.83万
-
财政年份:2013
-
负责人:Louis E. DeFrate
-
依托单位:
The In Vivo Biomechanics of Lateral Ankle Ligament Injury and Reconstruction
-
批准号:7876887
-
项目类别:
-
资助金额:$7.72万
-
财政年份:2008
-
负责人:Louis E. DeFrate
-
依托单位:
The In Vivo Biomechanics of Lateral Ankle Ligament Injury and Reconstruction
-
批准号:7683901
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2008
-
负责人:Louis E. DeFrate
-
依托单位:
The In Vivo Biomechanics of Lateral Ankle Ligament Injury and Reconstruction
-
批准号:7530457
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2008
-
负责人:Louis E. DeFrate
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: